Company Description

Guard Therapeutics is a research company that identifies and develops new therapies for diseases with a large medical need for effective treatments. The company is developing clinical drug candidate RMC-035 as a protective treatment against AKI, with an initial focus on cardiac surgery patients.

Sector: Healthcare
Market: First North Stockholm
Ticker: GUARD

Webpage
Penser Play

 

 

Latest research | 21 Sep 2023 | Guard Therapeutics

Resurrection

Read research